Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse.

Fos C, Salles A, Lang V, Carrette F, Audebert S, Pastor S, Ghiotto M, Olive D, Bismuth G, Nunès JA.

J Immunol. 2008 Aug 1;181(3):1969-77.

3.

Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.

Watanabe R, Harada Y, Takeda K, Takahashi J, Ohnuki K, Ogawa S, Ohgai D, Kaibara N, Koiwai O, Tanabe K, Toma H, Sugamura K, Abe R.

J Immunol. 2006 Jul 15;177(2):1085-91.

5.

AILIM/ICOS-mediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade.

Nukada Y, Okamoto N, Konakahara S, Tezuka K, Ohashi K, Mizuno K, Tsuji T.

Int Immunol. 2006 Dec;18(12):1815-24. Epub 2006 Oct 31.

PMID:
17077177
6.

IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.

Taylor A, Akdis M, Joss A, Akkoç T, Wenig R, Colonna M, Daigle I, Flory E, Blaser K, Akdis CA.

J Allergy Clin Immunol. 2007 Jul;120(1):76-83. Epub 2007 May 25.

PMID:
17531298
7.

Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Acosta YY, Zafra MP, Ojeda G, Bernardone IS, Dianzani U, Portolés P, Rojo JM.

Cell Mol Life Sci. 2011 Sep;68(18):3065-79. doi: 10.1007/s00018-010-0606-1. Epub 2010 Dec 28.

PMID:
21188463
8.

A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.

Nurieva RI, Chuvpilo S, Wieder ED, Elkon KB, Locksley R, Serfling E, Dong C.

J Immunol. 2007 Jul 15;179(2):1096-103.

10.

The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.

De Gregorio G, Coppa A, Cosentino C, Ucci S, Messina S, Nicolussi A, D'Inzeo S, Di Pardo A, Avvedimento EV, Porcellini A.

Oncogene. 2007 Mar 29;26(14):2039-47. Epub 2006 Oct 9.

PMID:
17043656
12.

A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).

Harada Y, Ohgai D, Watanabe R, Okano K, Koiwai O, Tanabe K, Toma H, Altman A, Abe R.

J Exp Med. 2003 Jan 20;197(2):257-62.

13.

A genetic library screen for signaling proteins that interact with phosphorylated T cell costimulatory receptors.

Zang X, Loke P, Kim J, Wojnoonski K, Kusdra L, Allison JP.

Genomics. 2006 Dec;88(6):841-5. Epub 2006 Oct 2.

14.

Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.

Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):7809-14. Epub 2007 Apr 30.

15.

Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node.

Matheu MP, Deane JA, Parker I, Fruman DA, Cahalan MD.

J Immunol. 2007 Aug 15;179(4):2261-9.

16.

Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?

Geering B, Cutillas PR, Vanhaesebroeck B.

Biochem Soc Trans. 2007 Apr;35(Pt 2):199-203. Review.

PMID:
17371237
17.
18.

Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways.

Feito MJ, Vaschetto R, Criado G, Sánchez A, Chiocchetti A, Jiménez-Periáñez A, Dianzani U, Portoles P, Rojo JM.

Eur J Immunol. 2003 Jan;33(1):204-14.

19.

The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase.

Alvarez-Errico D, Sayós J, López-Botet M.

J Immunol. 2007 Jan 15;178(2):808-16.

20.

Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.

Horn S, Bergholz U, Jücker M, McCubrey JA, Trümper L, Stocking C, Bäsecke J.

Oncogene. 2008 Jul 3;27(29):4096-106. doi: 10.1038/onc.2008.40. Epub 2008 Mar 3.

PMID:
18317450

Supplemental Content

Support Center